ExonSkipAD: functional annotation of exon skipping event in human

Gene summary for HNRNPA2B1

Gene summary

Gene information	Gene symbol	HNRNPA2B1
	Gene ID	3181
	Gene name	heterogeneous nuclear ribonucleoprotein A2/B1
	Synonyms	HNRNPA2\|HNRNPB1\|HNRPA2\|HNRPA2B1\|HNRPB1\|IBMPFD2\|RNPA2\|SNRPB1
	Cytomap	7p15.2
	Type of gene	protein-coding
	Description	heterogeneous nuclear ribonucleoproteins A2/B1HNRNPA2B1/MYC fusionepididymis secretory sperm binding proteinhnRNP A2 / hnRNP B1nuclear ribonucleoprotein particle A2 protein
	Modification date	20200314
	UniProtAcc	A0A087WUI2, I6L957, P22626,
	Context

Gene ontology of each this gene with evidence of Inferred from Direct Assay (IDA) from Entrez

Gene	GO ID	GO term	PubMed ID
HNRNPA2B1	GO:0006397	mRNA processing	2557628
HNRNPA2B1	GO:0006406	mRNA export from nucleus	10567417
HNRNPA2B1	GO:0031053	primary miRNA processing	26321680
HNRNPA2B1	GO:0050658	RNA transport	17004321
HNRNPA2B1	GO:1990428	miRNA transport	24356509

Top

Gene structures and expression levels for HNRNPA2B1

Skipped exons in the ROSMAP, MSBB, and Mayo based on Ensembl gene isoform structure.
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

ENSG00000122566

Differentially expressed gene analysis across multiple brain tissues between AD and control.

Tissue type

DEG direction

Base mean exp.

log2FC(AD/control)

P-value

Adj. p-value

Differentially expressed isoform analysis across multiple brain tissues between AD and control.

Tissue type	DEG direction	ENST	Transcript info.	Base mean exp.	log2FC(AD/control)	P-value	Adjc. p-value
CB	UP	ENST00000490912.5	HNRNPA2B1-206:retained_intron:HNRNPA2B1	1.700365e+01	1.411509e+00	3.047383e-06	3.870877e-05

Landscape of isoform expressions across multiple brain tissues between AD and control.

Top

Exon skipping events with PSIs in ROSMAP, MSBB, and Mayo for HNRNPA2B1

Landscape of individual exon skipping event across AD tissues and controls (PSI heatmap).

All exon skipping events in AD cohorts.

Exon skip ID	chr	Exons involved in exon skipping	Skipped exon
exon_skip_102724	chr7	26197625:26197732:26197831:26197866:26200572:26200746	26197831:26197866
exon_skip_129255	chr7	26191849:26192338:26192495:26192577:26193251:26193373	26192495:26192577
exon_skip_130926	chr7	26196585:26196658:26196807:26197017:26197315:26197461	26196807:26197017
exon_skip_137886	chr7	26190125:26190460:26190993:26191128:26192495:26192577	26190993:26191128
exon_skip_152325	chr7	26197624:26197732:26197831:26197866:26200572:26200746	26197831:26197866
exon_skip_18365	chr7	26197622:26197732:26197831:26197866:26200572:26200668	26197831:26197866
exon_skip_187492	chr7	26192301:26192338:26192495:26192577:26193251:26193373	26192495:26192577
exon_skip_188648	chr7	26196401:26196481:26196557:26196658:26196807:26196907	26196557:26196658
exon_skip_190599	chr7	26190443:26190460:26190993:26191128:26192495:26192528	26190993:26191128
exon_skip_20441	chr7	26193670:26193694:26195847:26195909:26196401:26196481	26195847:26195909
exon_skip_20823	chr7	26192495:26192577:26193251:26193373:26193575:26193694	26193251:26193373
exon_skip_210726	chr7	26197622:26197732:26197831:26197866:26200572:26200746	26197831:26197866
exon_skip_226286	chr7	26196807:26197017:26197315:26197461:26197622:26197730	26197315:26197461
exon_skip_227398	chr7	26195847:26195909:26196401:26196481:26196557:26196658	26196401:26196481
exon_skip_231004	chr7	26196455:26196481:26196557:26196658:26196807:26196907	26196557:26196658
exon_skip_232769	chr7	26195847:26195909:26196401:26196481:26196557:26196653	26196401:26196481
exon_skip_23376	chr7	26192495:26192577:26193251:26193373:26193575:26193589	26193251:26193373
exon_skip_270350	chr7	26196807:26197017:26197315:26197461:26197622:26197732	26197315:26197461
exon_skip_279249	chr7	26190125:26190460:26190993:26191128:26192495:26192528	26190993:26191128
exon_skip_42851	chr7	26193680:26193694:26195847:26195909:26196401:26196481	26195847:26195909
exon_skip_83570	chr7	26192495:26192577:26193251:26193373:26193575:26193634	26193251:26193373
exon_skip_99767	chr7	26193251:26193373:26193575:26193694:26195847:26195855	26193575:26193694

Differentially expressed PSI values of individual exon skipping events in multiple brain tissues between AD and control.

Exon skipping information

Tissue type

Avg(PSIs) in AD

Avg(PSIs) in control

Difference (PSI)

Adj. p-value

Top

Open reading frame (ORF) annotation in the exon skipping event for HNRNPA2B1

Open reading frame (ORF) of individual exon skipping events in ROSMAP based on the Ensembl gene structure combined from isoforms.

ENST	Start of skipped exon	End of skipped exon	ORF
ENST00000354667	26192495	26192577	5CDS-5UTR
ENST00000354667	26193251	26193373	In-frame
ENST00000354667	26193575	26193694	In-frame
ENST00000354667	26196401	26196481	In-frame
ENST00000354667	26196557	26196658	In-frame
ENST00000354667	26197315	26197461	In-frame
ENST00000354667	26197831	26197866	In-frame

Open reading frame (ORF) of individual exon skipping events in MSBB based on the Ensembl gene structure combined from isoforms.

ENST	Start of skipped exon	End of skipped exon	ORF
ENST00000354667	26197831	26197866	In-frame

Open reading frame (ORF) of individual exon skipping events in Mayo based on the Ensembl gene structure combined from isoforms.

ENST	Start of skipped exon	End of skipped exon	ORF
ENST00000354667	26192495	26192577	5CDS-5UTR
ENST00000354667	26196807	26197017	Frame-shift
ENST00000354667	26193251	26193373	In-frame
ENST00000354667	26193575	26193694	In-frame
ENST00000354667	26195847	26195909	In-frame
ENST00000354667	26196401	26196481	In-frame
ENST00000354667	26196557	26196658	In-frame
ENST00000354667	26197315	26197461	In-frame
ENST00000354667	26197831	26197866	In-frame

Top

Infer the effects of exon skipping event on protein functional features for HNRNPA2B1

p-ENSG00000122566_img4.png
boxplot

Loci of skipped exons in ROSMAP across genomic, transcript, and protein sequence levels of In-frame cases.

ENST	Length of mRNA	Length of AA seq.	Genomic start	Genomic end	mRNA start	mRNA end	AA start	AA end
ENST00000354667	3681	353	26197831	26197866	176	210	2	13
ENST00000354667	3681	353	26197315	26197461	323	468	51	99
ENST00000354667	3681	353	26196557	26196658	681	781	170	204
ENST00000354667	3681	353	26196401	26196481	783	862	204	231
ENST00000354667	3681	353	26193575	26193694	927	1045	252	292
ENST00000354667	3681	353	26193251	26193373	1047	1168	292	333

Loci of skipped exons in MSBB across genomic, transcript, and protein sequence levels of In-frame cases.

ENST	Length of mRNA	Length of AA seq.	Genomic start	Genomic end	mRNA start	mRNA end	AA start	AA end
ENST00000354667	3681	353	26197831	26197866	176	210	2	13

Loci of skipped exons in Mayo across genomic, transcript, and protein sequence levels of In-frame cases.

ENST	Length of mRNA	Length of AA seq.	Genomic start	Genomic end	mRNA start	mRNA end	AA start	AA end
ENST00000354667	3681	353	26197831	26197866	176	210	2	13
ENST00000354667	3681	353	26197315	26197461	323	468	51	99
ENST00000354667	3681	353	26196557	26196658	681	781	170	204
ENST00000354667	3681	353	26196401	26196481	783	862	204	231
ENST00000354667	3681	353	26195847	26195909	864	925	231	252
ENST00000354667	3681	353	26193575	26193694	927	1045	252	292
ENST00000354667	3681	353	26193251	26193373	1047	1168	292	333

Lost protein functional features of individual exon skipping events in ROSMAP.

UniProt acc.	Start of exon skipping (AA)	End of exon skipping (AA)	Protein feature start (AA)	Protein feature end (AA)	Category of protein feature	Description of feature
P22626	2	13	3	14	Alternative sequence	ID=VSP_005830;Note=In isoform A2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303\|PubMed:2557628;Dbxref=PMID:2557628
P22626	2	13	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	2	13	4	4	Modified residue	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:23186163;Dbxref=PMID:23186163
P22626	2	13	9	15	Motif	Note=Nuclear localization signal;Ontology_term=ECO:0000255;evidence=ECO:0000255
P22626	51	99	47	54	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	61	71	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	83	86	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:1X4B
P22626	51	99	92	95	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	51	99	21	104	Domain	Note=RRM 1;Ontology_term=ECO:0000255;evidence=ECO:0000255\|PROSITE-ProRule:PRU00176
P22626	51	99	72	80	Helix	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	99	101	Helix	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	85	85	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:19690332,ECO:0000244\|PubMed:20068231,ECO:0000244\|PubMed:24275569;Dbxref=PMID:19690332,PMID:20068231,PMID:24275569
P22626	51	99	56	58	Turn	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	170	204	174	177	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	170	204	180	186	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	170	204	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	170	204	202	353	Compositional bias	Note=Gly-rich
P22626	170	204	173	173	Cross-link	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:28112733;Dbxref=PMID:28112733
P22626	170	204	186	186	Cross-link	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:25218447;Dbxref=PMID:25218447
P22626	170	204	112	191	Domain	Note=RRM 2;Ontology_term=ECO:0000255;evidence=ECO:0000255\|PROSITE-ProRule:PRU00176
P22626	170	204	173	173	Modified residue	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:19608861;Dbxref=PMID:19608861
P22626	170	204	176	176	Modified residue	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:23186163;Dbxref=PMID:23186163
P22626	170	204	189	189	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:23186163;Dbxref=PMID:23186163
P22626	170	204	201	201	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:23186163;Dbxref=PMID:23186163
P22626	170	204	203	203	Modified residue	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250\|UniProtKB:O88569
P22626	170	204	203	203	Modified residue	Note=Dimethylated arginine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269\|Ref.6
P22626	170	204	203	203	Modified residue	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244\|PubMed:15782174,ECO:0000244\|PubMed:24129315,ECO:0000269\|Ref.6;Dbxref=PMID:15782174,PMID:24129315
P22626	170	204	193	353	Region	Note=Low complexity (LC) region;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	170	204	190	192	Turn	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	204	231	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	204	231	202	353	Compositional bias	Note=Gly-rich
P22626	204	231	212	212	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:19690332,ECO:0000244\|PubMed:20068231,ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:23186163,ECO:0000244\|PubMed:24275569;Dbxref=PMID:1
P22626	204	231	213	213	Modified residue	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250\|UniProtKB:O88569
P22626	204	231	213	213	Modified residue	Note=Dimethylated arginine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269\|Ref.6
P22626	204	231	213	213	Modified residue	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244\|PubMed:24129315,ECO:0000269\|Ref.6;Dbxref=PMID:24129315
P22626	204	231	225	225	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:20068231,ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:23186163,ECO:0000244\|PubMed:24275569;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163,PMID
P22626	204	231	228	228	Modified residue	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:24129315;Dbxref=PMID:24129315
P22626	204	231	231	231	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:20068231,ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:24275569;Dbxref=PMID:20068231,PMID:21406692,PMID:24275569
P22626	204	231	207	207	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	209	209	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	219	219	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	227	227	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	193	353	Region	Note=Low complexity (LC) region;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	205	205	Sequence conflict	Note=G->S;Ontology_term=ECO:0000305;evidence=ECO:0000305
P22626	252	292	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	252	292	202	353	Compositional bias	Note=Gly-rich
P22626	252	292	259	259	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:17924679,ECO:0000244\|PubMed:18220336,ECO:0000244\|PubMed:18669648,ECO:0000244\|PubMed:18
P22626	252	292	266	266	Modified residue	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250\|UniProtKB:A7VJC2
P22626	252	292	266	266	Modified residue	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:24129315;Dbxref=PMID:24129315
P22626	252	292	256	256	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	262	262	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	269	269	Mutagenesis	Note=Does not affect hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	276	276	Mutagenesis	Note=Impairs hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	283	283	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	287	287	Mutagenesis	Note=Does not affect hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	290	290	Mutagenesis	Note=Impairs hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	193	353	Region	Note=Low complexity (LC) region;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	292	333	202	353	Compositional bias	Note=Gly-rich
P22626	292	333	324	324	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:23186163;Dbxref=PMID:21406692,PMID:23186163
P22626	292	333	325	325	Modified residue	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:24129315;Dbxref=PMID:24129315
P22626	292	333	331	331	Modified residue	Note=Phosphotyrosine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:23186163;Dbxref=PMID:21406692,PMID:23186163
P22626	292	333	295	295	Mutagenesis	Note=Impairs hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	300	300	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	303	303	Mutagenesis	Note=Impairs hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	306	306	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	313	313	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	321	321	Mutagenesis	Note=Impairs hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	331	331	Mutagenesis	Note=Impairs hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	302	302	Natural variant	ID=VAR_070591;Note=In IBMPFD2. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:23455423;Dbxref=dbSNP:rs397515326,PMID:23455423
P22626	292	333	193	353	Region	Note=Low complexity (LC) region;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	308	347	Region	Note=Nuclear targeting sequence;Ontology_term=ECO:0000250;evidence=ECO:0000250

Lost protein functional features of individual exon skipping events in MSBB.

UniProt acc.	Start of exon skipping (AA)	End of exon skipping (AA)	Protein feature start (AA)	Protein feature end (AA)	Category of protein feature	Description of feature
P22626	2	13	3	14	Alternative sequence	ID=VSP_005830;Note=In isoform A2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303\|PubMed:2557628;Dbxref=PMID:2557628
P22626	2	13	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	2	13	4	4	Modified residue	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:23186163;Dbxref=PMID:23186163
P22626	2	13	9	15	Motif	Note=Nuclear localization signal;Ontology_term=ECO:0000255;evidence=ECO:0000255

Lost protein functional features of individual exon skipping events in Mayo.

UniProt acc.	Start of exon skipping (AA)	End of exon skipping (AA)	Protein feature start (AA)	Protein feature end (AA)	Category of protein feature	Description of feature
P22626	2	13	3	14	Alternative sequence	ID=VSP_005830;Note=In isoform A2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303\|PubMed:2557628;Dbxref=PMID:2557628
P22626	2	13	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	2	13	4	4	Modified residue	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:23186163;Dbxref=PMID:23186163
P22626	2	13	9	15	Motif	Note=Nuclear localization signal;Ontology_term=ECO:0000255;evidence=ECO:0000255
P22626	51	99	47	54	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	61	71	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	83	86	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:1X4B
P22626	51	99	92	95	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	51	99	21	104	Domain	Note=RRM 1;Ontology_term=ECO:0000255;evidence=ECO:0000255\|PROSITE-ProRule:PRU00176
P22626	51	99	72	80	Helix	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	99	101	Helix	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	51	99	85	85	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:19690332,ECO:0000244\|PubMed:20068231,ECO:0000244\|PubMed:24275569;Dbxref=PMID:19690332,PMID:20068231,PMID:24275569
P22626	51	99	56	58	Turn	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	170	204	174	177	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	170	204	180	186	Beta strand	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	170	204	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	170	204	202	353	Compositional bias	Note=Gly-rich
P22626	170	204	173	173	Cross-link	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:28112733;Dbxref=PMID:28112733
P22626	170	204	186	186	Cross-link	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:25218447;Dbxref=PMID:25218447
P22626	170	204	112	191	Domain	Note=RRM 2;Ontology_term=ECO:0000255;evidence=ECO:0000255\|PROSITE-ProRule:PRU00176
P22626	170	204	173	173	Modified residue	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:19608861;Dbxref=PMID:19608861
P22626	170	204	176	176	Modified residue	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:23186163;Dbxref=PMID:23186163
P22626	170	204	189	189	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:23186163;Dbxref=PMID:23186163
P22626	170	204	201	201	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:23186163;Dbxref=PMID:23186163
P22626	170	204	203	203	Modified residue	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250\|UniProtKB:O88569
P22626	170	204	203	203	Modified residue	Note=Dimethylated arginine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269\|Ref.6
P22626	170	204	203	203	Modified residue	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244\|PubMed:15782174,ECO:0000244\|PubMed:24129315,ECO:0000269\|Ref.6;Dbxref=PMID:15782174,PMID:24129315
P22626	170	204	193	353	Region	Note=Low complexity (LC) region;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	170	204	190	192	Turn	Ontology_term=ECO:0000244;evidence=ECO:0000244\|PDB:5HO4
P22626	204	231	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	204	231	202	353	Compositional bias	Note=Gly-rich
P22626	204	231	212	212	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:19690332,ECO:0000244\|PubMed:20068231,ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:23186163,ECO:0000244\|PubMed:24275569;Dbxref=PMID:1
P22626	204	231	213	213	Modified residue	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250\|UniProtKB:O88569
P22626	204	231	213	213	Modified residue	Note=Dimethylated arginine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269\|Ref.6
P22626	204	231	213	213	Modified residue	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244\|PubMed:24129315,ECO:0000269\|Ref.6;Dbxref=PMID:24129315
P22626	204	231	225	225	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:20068231,ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:23186163,ECO:0000244\|PubMed:24275569;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163,PMID
P22626	204	231	228	228	Modified residue	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:24129315;Dbxref=PMID:24129315
P22626	204	231	231	231	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:20068231,ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:24275569;Dbxref=PMID:20068231,PMID:21406692,PMID:24275569
P22626	204	231	207	207	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	209	209	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	219	219	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	227	227	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	193	353	Region	Note=Low complexity (LC) region;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	204	231	205	205	Sequence conflict	Note=G->S;Ontology_term=ECO:0000305;evidence=ECO:0000305
P22626	231	252	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	231	252	202	353	Compositional bias	Note=Gly-rich
P22626	231	252	231	231	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:20068231,ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:24275569;Dbxref=PMID:20068231,PMID:21406692,PMID:24275569
P22626	231	252	236	236	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:21406692;Dbxref=PMID:21406692
P22626	231	252	238	238	Modified residue	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:24129315;Dbxref=PMID:24129315
P22626	231	252	234	234	Mutagenesis	Note=Does not affect hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	231	252	240	240	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	231	252	244	244	Mutagenesis	Note=Does not affect hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	231	252	247	247	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	231	252	193	353	Region	Note=Low complexity (LC) region;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	252	292	202	353	Compositional bias	Note=Gly-rich
P22626	252	292	259	259	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:17924679,ECO:0000244\|PubMed:18220336,ECO:0000244\|PubMed:18669648,ECO:0000244\|PubMed:18
P22626	252	292	266	266	Modified residue	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250\|UniProtKB:A7VJC2
P22626	252	292	266	266	Modified residue	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:24129315;Dbxref=PMID:24129315
P22626	252	292	256	256	Mutagenesis	Note=Does not affect hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	262	262	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	269	269	Mutagenesis	Note=Does not affect hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	276	276	Mutagenesis	Note=Impairs hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	283	283	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	287	287	Mutagenesis	Note=Does not affect hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	290	290	Mutagenesis	Note=Impairs hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	252	292	193	353	Region	Note=Low complexity (LC) region;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	1	353	Chain	ID=PRO_0000081836;Note=Heterogeneous nuclear ribonucleoproteins A2/B1
P22626	292	333	202	353	Compositional bias	Note=Gly-rich
P22626	292	333	324	324	Modified residue	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:23186163;Dbxref=PMID:21406692,PMID:23186163
P22626	292	333	325	325	Modified residue	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244\|PubMed:24129315;Dbxref=PMID:24129315
P22626	292	333	331	331	Modified residue	Note=Phosphotyrosine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244\|PubMed:21406692,ECO:0000244\|PubMed:23186163;Dbxref=PMID:21406692,PMID:23186163
P22626	292	333	295	295	Mutagenesis	Note=Impairs hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	300	300	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	303	303	Mutagenesis	Note=Impairs hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	306	306	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	313	313	Mutagenesis	Note=Slightly affects hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	321	321	Mutagenesis	Note=Impairs hydrogel-binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	331	331	Mutagenesis	Note=Impairs hydrogel-binding. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	302	302	Natural variant	ID=VAR_070591;Note=In IBMPFD2. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:23455423;Dbxref=dbSNP:rs397515326,PMID:23455423
P22626	292	333	193	353	Region	Note=Low complexity (LC) region;Ontology_term=ECO:0000269;evidence=ECO:0000269\|PubMed:26544936;Dbxref=PMID:26544936
P22626	292	333	308	347	Region	Note=Nuclear targeting sequence;Ontology_term=ECO:0000250;evidence=ECO:0000250

Top

3'-UTR located exon skipping events that lost miRNA binding sites in HNRNPA2B1

3'-UTR exon skipping evnets lost miRNA binding.

Tissue type

ENST

Exon skip start

Exon skip end

microRNA

Binding site by TargetScan

Binding type by TargetScan

Bdinding site by miRanda

Score of miRanda

Energy by miRanda

Top

SNVs in the skipped exons for HNRNPA2B1

- Differential PSIs between mutated versus non-mutated samples.

- Depth of Coverage in the skipped exon of the mutated samples.

- Sashimi plot in the skipped exon of the mutated samples.

- Non-synonymous mutations located in the skipped exons.

Cancer type

Sample

ESID

Skipped exon start

Skipped exon end

Mutation start

Mutation end

Mutation type

Reference seq

Mutation seq

AAchange

- Non-synonymous mutations located in the skipped exons in CCLE.

Sample

Skipped exon start

Skipped exon end

Mutation start

Mutation end

Mutation type

Reference seq

Mutation seq

AAchange

Top

AD stage-associated exon skippint events for HNRNPA2B1

Associated exon skipping events with Braak staging or Clinical Dementia Rating (CDR).

AD stage info

Cohort

Tissue

SE id

Coefficient

P-value

Chromosome

Strand

E1 start

E1 end

Skipped start

Skipped end

E2 start

E2 end

Top

Splicing Quantitative Trait Loci (sQTL) in the exon skipping event for HNRNPA2B1

sQTL information located at the skipped exons.

Tissue type

Exon skip ID

SNP id

Location

P-value

FDR

Top

Correlation with RNA binding proteins (RBPs) for HNRNPA2B1

Correlated RBP and related information.

Tissue type	RBP name	Exon skip ID	Correlation coeifficient	P-value
CB	RBFOX2	exon_skip_132256	-4.006529e-01	5.928069e-07
CB	MBNL1	exon_skip_132256	-4.167010e-01	1.853747e-07
CB	MATR3	exon_skip_132256	-4.056715e-01	4.148180e-07
CB	PCBP1	exon_skip_132256	-4.498850e-01	1.371146e-08
CB	HNRNPK	exon_skip_132256	-4.284388e-01	7.616860e-08
CB	PCBP2	exon_skip_132256	-4.987556e-01	1.719079e-10
CB	RC3H1	exon_skip_132256	-4.167099e-01	1.852527e-07
CB	G3BP2	exon_skip_132256	-4.513893e-01	1.210300e-08
CB	KHDRBS2	exon_skip_132256	-4.072153e-01	3.712336e-07
CB	KHDRBS3	exon_skip_132256	-4.182530e-01	1.651261e-07
CB	HNRNPA0	exon_skip_132256	-4.804928e-01	9.576477e-10
CB	HNRNPC	exon_skip_132256	-4.226067e-01	1.189971e-07
CB	RALY	exon_skip_132256	-4.631658e-01	4.461504e-09
CB	PTBP3	exon_skip_132256	-4.079815e-01	3.512593e-07
CB	HNRNPL	exon_skip_132256	-5.060187e-01	8.437384e-11
CB	SRSF4	exon_skip_132256	-4.015965e-01	5.545678e-07
CB	SRSF9	exon_skip_132256	-4.366283e-01	4.012959e-08
CB	HNRNPH2	exon_skip_132256	-4.515615e-01	1.193091e-08
CB	EIF4B	exon_skip_132256	-4.847424e-01	6.479459e-10
CB	HNRNPF	exon_skip_132256	-4.189556e-01	1.566707e-07
CB	DAZAP1	exon_skip_1060	-4.232680e-01	2.719069e-08
CB	TRNAU1AP	exon_skip_1060	-4.703634e-01	3.952170e-10
CB	KHSRP	exon_skip_1060	-4.237304e-01	2.616421e-08
CB	DAZAP1	exon_skip_250618	-4.439580e-01	4.586043e-09
CB	TARDBP	exon_skip_250618	-4.678282e-01	5.046940e-10
CB	ELAVL1	exon_skip_250618	-4.259390e-01	2.175302e-08
CB	SAMD4A	exon_skip_250618	-4.443584e-01	4.425489e-09
CB	U2AF2	exon_skip_250618	-5.005530e-01	1.833061e-11
CB	CNOT4	exon_skip_250618	-4.727611e-01	3.130408e-10
CB	TRNAU1AP	exon_skip_250618	-5.089700e-01	7.370886e-12
CB	PCBP1	exon_skip_250618	-4.232120e-01	2.731777e-08
CB	TRA2A	exon_skip_250618	-4.806319e-01	1.437902e-10
CB	ENOX1	exon_skip_250618	-4.031683e-01	1.371541e-07
CB	KHSRP	exon_skip_250618	-4.596387e-01	1.096960e-09
CB	HNRNPAB	exon_skip_250618	-4.489945e-01	2.919555e-09
CB	HNRNPC	exon_skip_250618	-4.773031e-01	2.002969e-10
CB	EIF4G2	exon_skip_250618	-4.158800e-01	4.990085e-08
CB	PTBP1	exon_skip_250618	-4.171927e-01	4.484541e-08
CB	HNRNPL	exon_skip_250618	-4.097199e-01	8.187936e-08
CB	SRSF1	exon_skip_250618	-4.013556e-01	1.578886e-07
CB	SRSF4	exon_skip_250618	-5.002760e-01	1.888056e-11
CB	HNRNPF	exon_skip_250618	-4.722343e-01	3.295413e-10
TC	ELAVL4	exon_skip_154753	-4.579753e-01	1.135433e-09
TC	RBM3	exon_skip_154753	-4.961356e-01	2.534292e-11
TC	ILF2	exon_skip_154753	-4.351883e-01	8.881882e-09
TC	KHDRBS2	exon_skip_154753	-4.694395e-01	3.804164e-10
TC	HNRNPA0	exon_skip_154753	-5.312960e-01	4.904597e-13
TC	HNRNPDL	exon_skip_154753	-4.304877e-01	1.332723e-08
TC	HNRNPD	exon_skip_154753	-5.016169e-01	1.410888e-11
TC	NUP42	exon_skip_154753	-4.731626e-01	2.643724e-10
TC	RALYL	exon_skip_154753	-4.315780e-01	1.213675e-08
TC	HNRNPH2	exon_skip_154753	-5.101460e-01	5.553750e-12
TC	ESRP1	exon_skip_154753	-4.007736e-01	1.508644e-07
TC	NOVA1	exon_skip_154753	-4.364529e-01	7.954838e-09
TC	RBMS1	exon_skip_171726	-4.257914e-01	1.986794e-08
TC	MBNL1	exon_skip_171726	-4.011407e-01	1.466156e-07
TC	PTBP3	exon_skip_171726	-4.127715e-01	5.825237e-08

Top

RelatedDrugs for HNRNPA2B1

Approved drugs targeting this gene.
(DrugBank Version 5.1.0 2018-04-02)

UniProtAcc

DrugBank ID

Drug name

Drug activity

Drug type

Drug status

Top

RelatedDiseases for HNRNPA2B1

Diseases associated with this gene.
(DisGeNet 4.0)

Gene

Disease ID

Disease name

# pubmeds

Source

	Gene summary
	Gene structures and expression levels
	Exon skipping events with PSIs in RPSMAP, MSBB, and Mayo
	Open reading frame (ORF) annotation in the exon skipping event
	Exon skipping events in the canonical protein sequence
	3'-UTR located exon skipping events lost miRNA binding sites
	SNVs in the skipped exons with depth of coverage
	AD stage-associated exon skipping events
	Splicing Quantitative Trait Loci (sQTLs) in the skipped exons
	Correlation with RNA binding proteins (RBPs)
	Related drugs with this gene
	Related diseases with this gene

Home

Download

Statistics

Landscape

Help

Contact

Gene summary for HNRNPA2B1

Gene structures and expression levels for HNRNPA2B1

Exon skipping events with PSIs in ROSMAP, MSBB, and Mayo for HNRNPA2B1

Open reading frame (ORF) annotation in the exon skipping event for HNRNPA2B1

Infer the effects of exon skipping event on protein functional features for HNRNPA2B1

3'-UTR located exon skipping events that lost miRNA binding sites in HNRNPA2B1

SNVs in the skipped exons for HNRNPA2B1

AD stage-associated exon skippint events for HNRNPA2B1

Splicing Quantitative Trait Loci (sQTL) in the exon skipping event for HNRNPA2B1

Correlation with RNA binding proteins (RBPs) for HNRNPA2B1

RelatedDrugs for HNRNPA2B1

RelatedDiseases for HNRNPA2B1